Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Greater Europe Investment Trust Regulatory News (BRGE)

Share Price Information for BlackRock Greater Europe Investment Trust (BRGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 624.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.32%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 624.00
BRGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

14 Oct 2019 16:30

BlackRock Greater Europe Investment Trust Plc - Portfolio Update

BlackRock Greater Europe Investment Trust Plc - Portfolio Update

PR Newswire

London, October 14

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc (LEI - 5493003R8FJ6I76ZUW55)All information is at 30 September 2019 and unaudited.Performance at month end with net income reinvested 

One MonthThree MonthsOne YearThree YearsLaunch (20 Sep 04)
Net asset value (undiluted)0.0%-0.2%6.9%43.8%422.7%
Net asset value* (diluted)0.0%-0.2%6.9%43.8%423.1%
Share price-0.5%0.5%8.7%45.7%406.1%
FTSE World Europe ex UK1.0%1.6%6.3%33.1%272.3%

* Diluted for treasury shares and subscription shares.Sources: BlackRock and Datastream 

At month end

Net asset value (capital only):396.07p
Net asset value (including income):399.37p
Net asset value (capital only)1:396.07p
Net asset value (including income)1:399.37p
Share price:383.00p
Discount to NAV (including income):4.1%
Discount to NAV (including income)1:4.1%
Net gearing:1.4%
Net yield2:1.5%
Total assets (including income):£337.5m
Ordinary shares in issue3:84,518,101
Ongoing charges4:1.09%

1 Diluted for treasury shares.2 Based on a final dividend of 4.00p per share for the year ended 31 August 2018 and an interim dividend of 1.75p for the year ending 31 August 2019.3 Excluding 25,810,837 shares held in treasury.4 Calculated as a percentage of average net assets and using expenses, excluding interest costs, after relief for taxation, for the year ended 31 August 2018.

Sector AnalysisTotal Assets (%)Country AnalysisTotal Assets (%)
Industrials26.4Denmark16.8
Health Care20.2France16.5
Technology17.3Germany14.5
Consumer Goods16.8Switzerland14.5
Financials8.9Italy7.9
Consumer Services6.1Netherlands6.7
Basic Materials3.2Spain5.1
Telecommunications1.6Sweden5.0
Net current liabilities-0.5United Kingdom4.5
-----Israel2.7
100.0Poland2.0
=====Ireland1.8
Belgium1.6
Greece0.9
Net current liabilities -0.5
-----
100.0
=====

Ten Largest Equity Investments
CompanyCountry% of Total Assets
SafranFrance7.1
Novo NordiskDenmark6.4
AdidasGermany6.1
SAPGermany5.7
SikaSwitzerland5.2
Royal UnibrewDenmark4.8
Lonza GroupSwitzerland4.5
ASMLNetherlands4.5
DSVDenmark4.5
RELXUnited Kingdom4.5

Commenting on the markets, Stefan Gries, representing the Investment Manager noted:

During the month, the Company’s NAV was flat, returning 0% and the share price fell by 0.5%. For reference, the FTSE World Europe Ex UK Index returned +1.0% during the period.

The market experienced a reversal over the month, where stocks that had been performing well began to underperform those out of favour stocks. This reversal proved wide spread and based on market positioning, with many of those less well owned names in the market rerating without fundamental grounding. This market unwind came from an extreme position at the end of August, following one of the sharpest downward moves in government bond yields in a single month on record.

Economic data provided further evidence that trade disputes and broader geopolitical tensions continue to weigh on the global economy.

During the month, the European Central Bank (ECB) announced a broad package of easing measures including cutting the deposit rate by 10 basis points to -50 basis points, as well as restarting asset purchases at a pace of €20bn Euro per month, with a commitment to run the programme until its inflation target was met.

The Company underperformed the index over the month with both stock selection and sector allocation detracting from returns. The financials sector was the largest detractor to returns during September, as the sector saw the strongest returns in the index. Our selected position in KBC was positive; however, the overall underweight to the sector was negative for performance. We continue to hold our underweight position, as we believe banks remain structurally challenged given low interest rates and an oversupply in the sector. There was no part of the ECB statement which we believe alters this outlook.

A lower allocation to the oil & gas sector also detracted due to the rising oil price following the attacks on Saudi oil fields, though we note this has already reversed in full going into October.

The Company’s allocation to luxury goods proved challenging over the quarter as tariff fears and ongoing protests in Hong Kong weighed on the share prices. This included a position in LVMH, which detracted given the group’s mid single-digit sales exposure to Hong Kong. While we appreciate third quarter earnings might be slightly weaker than Q2, we still expect robust numbers and believe sales in mainland China and the US can partially offset weakness from Hong Kong.

For Rémy Cointreau, the same narrative proved challenging for the shares. However, the most recent data for August, had shown strength in the Asian and North American markets in demand for Cognac. We believe the group remains well positioned to flex their production and push up pricing in response to any potential tariff action from the US.

A holding in Safran was the top performer during the month after having reported impressive numbers across all divisions and raising growth forecasts for the rest of the year. The civil aftermarket continues to be strong, growing 10% in the first half of the year. Company management also confirmed that the LEAP engine roll-out is progressing well and that the turnaround of Zodiac, acquired in early 2018, is on track.

At the end of the period the Company had a higher allocation than the reference index towards industrials, technology, consumer services and health care. A lower allocation was held in financials, consumer goods, utilities, telecommunications, basic materials and oil & gas.

Outlook

The global economic environment is clearly deteriorating in response to the uncertainty caused by US-Chinese relations. We believe this has created disruption within supply chains and potential delays to capital expenditure, but do not see structural imbalances in the economy at this point in time. Policy remains supportive in Europe and the consumer resilient with Eurozone retail sales growing 2.6% year-on-year in June. Q2 earnings releases have unveiled a slowdown in short-cycle companies, however our portfolios are generally not exposed to these types of businesses. At present, we do not see contagion beyond this. Valuation dispersion within the market remains a topic of conversation, but we believe the prevailing environment and structural headwinds warrant ‘cheap valuations’ for some sectors. Our portfolio capital is positioned to where we see the best upside driven by fundamentals. Whilst markets can respond to statistical indicators in the near term, at times causing rotations, we believe company fundamentals drive long-term performance. We continue to have a small pro-cyclical tilt in portfolios, primarily expressed through late cycle industrials, such as aerospace stocks, and consumer exposed names, such as luxuries.

14 October 2019

ENDS

Latest information is available by typing www.brgeplc.co.uk on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
19th Jan 202212:09 pmPRNNet Asset Value(s)
18th Jan 20221:59 pmPRNIssue of Equity
18th Jan 202211:39 amPRNNet Asset Value(s)
17th Jan 202211:27 amPRNNet Asset Value(s)
17th Jan 20227:00 amPRNTotal Voting Rights
17th Jan 20227:00 amPRNBlocklisting - Interim Review
14th Jan 202211:54 amPRNNet Asset Value(s)
14th Jan 20227:00 amPRNTotal Voting Rights
13th Jan 20224:00 pmPRNIssue of Equity
13th Jan 202211:57 amPRNNet Asset Value(s)
13th Jan 20227:00 amPRNTotal Voting Rights
12th Jan 20224:33 pmPRNDirector/PDMR Shareholding
12th Jan 20222:46 pmPRNIssue of Equity
12th Jan 202212:33 pmPRNNet Asset Value(s)
11th Jan 20223:27 pmPRNIssue of Equity
11th Jan 202211:54 amPRNNet Asset Value(s)
11th Jan 20227:00 amPRNTotal Voting Rights
10th Jan 202211:58 amPRNNet Asset Value(s)
7th Jan 20222:08 pmPRNIssue of Equity
7th Jan 202211:42 amPRNNet Asset Value(s)
7th Jan 20227:00 amPRNTotal Voting Rights
6th Jan 202212:02 pmPRNNet Asset Value(s)
6th Jan 20227:00 amPRNTotal Voting Rights
5th Jan 20223:09 pmPRNIssue of Equity
5th Jan 202211:35 amPRNNet Asset Value(s)
5th Jan 20227:00 amPRNTotal Voting Rights
4th Jan 20223:34 pmPRNIssue of Equity
4th Jan 202211:45 amPRNNet Asset Value(s)
31st Dec 202112:31 pmPRNIssue of Equity
31st Dec 202111:32 amPRNNet Asset Value(s)
31st Dec 20217:00 amPRNTotal Voting Rights
30th Dec 202111:36 amPRNNet Asset Value(s)
29th Dec 20213:51 pmPRNIssue of Equity
29th Dec 202111:36 amPRNNet Asset Value(s)
29th Dec 20217:00 amPRNTotal Voting Rights
24th Dec 202111:21 amPRNNet Asset Value(s)
24th Dec 20217:00 amPRNTotal Voting Rights
23rd Dec 20212:46 pmPRNIssue of Equity
23rd Dec 202112:08 pmPRNNet Asset Value(s)
23rd Dec 20217:00 amPRNTotal Voting Rights
22nd Dec 20213:10 pmPRNIssue of Equity
22nd Dec 202111:42 amPRNNet Asset Value(s)
21st Dec 20213:00 pmPRNIssue of Equity
21st Dec 202111:27 amPRNNet Asset Value(s)
21st Dec 20217:00 amPRNTotal Voting Rights
20th Dec 20212:10 pmPRNPortfolio Update
20th Dec 202111:58 amPRNNet Asset Value(s)
20th Dec 20217:00 amPRNTotal Voting Rights
17th Dec 20214:23 pmPRNIssue of Equity
17th Dec 20211:00 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.